Persistent antidepressant effect of low-dose ketamine and activation in the supplementary motor area and anterior cingulate cortex in treatment-resistant depression: A randomized control study

被引:42
作者
Chen, Mu-Hong [1 ,2 ]
Li, Cheng-Ta [1 ,2 ,4 ]
Lin, Wei-Chen [2 ,4 ]
Hong, Chen-Jee [1 ,2 ,4 ]
Tu, Pei-Chi [1 ,2 ,3 ]
Bai, Ya-Mei [1 ,2 ]
Cheng, Chih-Ming [2 ]
Su, Tung-Ping [1 ,2 ,3 ,4 ,5 ]
机构
[1] Natl Yang Ming Univ, Fac Med, Div Psychiat, Taipei, Taiwan
[2] Taipei Vet Gen Hosp, Dept Psychiat, 201,Sec 2,Shih-Pai Rd, Taipei 112, Taiwan
[3] Taipei Vet Gen Hosp, Dept Med Res, Taipei, Taiwan
[4] Natl Yang Ming Univ, Inst Brain Sci, Taipei, Taiwan
[5] Gen Cheng Hsin Hosp, Dept Psychiat, Taipei, Taiwan
关键词
Ketamine; Treatment-resistant depression; PET; Supplementary motor area; Dorsal anterior cingulate cortex; UNIPOLAR DEPRESSION; RESIDUAL SYMPTOMS; PREFRONTAL CORTEX; PET SCANS; DISORDER; REMISSION; BRAIN; ADOLESCENTS; OUTCOMES; CARE;
D O I
10.1016/j.jad.2017.09.008
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: A single low-dose ketamine infusion exhibited a rapid antidepressant effect within 1 h. Despite its short biological half-life (approximately 3 h), the antidepressant effect of ketamine has been demonstrated to persist for several days. However, changes in brain function responsible for the persistent antidepressant effect of a single low-dose ketamine infusion remain unclear Methods: Twenty-four patients with treatment-resistant depression (TRD) were randomized into three groups according to the treatment received: 0.5 mg/kg ketamine, 0.2 mg/kg ketamine, and normal saline infusion. Standardized uptake values (SUVs) of glucose metabolism measured through F-18-FDG positron-emission-tomography before infusion and 1 day after a 40-min ketamine or normal saline infusion were used for subsequent whole-brain voxel-wise analysis and were correlated with depressive symptoms, as defined using the Hamilton Depression Rating Scale-17 (HDRS-17) score Results: The voxel-wise analysis revealed that patients with TRD receiving the 0.5 mg/kg ketamine infusion had significantly higher SUVs (corrected for family-wise errors, P = 0.014) in the supplementary motor area (SMA) and dorsal anterior cingulate cortex (dACC) than did those receiving the 0.2 mg/kg ketamine infusion. The increase in the SUV in the dACC was negatively correlated with depressive symptoms at 1 day after ketamine infusion Discussion: The persistent antidepressant effect of a 0.5 mg/kg ketamine infusion may be mediated by increased activation in the SMA and dACC. The higher increase in dACC activation was related to the reduction in depressive symptoms after ketamine infusion. A 0.5 mg/kg ketamine infusion facilitated the glutamatergic neurotransmission in the SMA and dACC, which may be responsible for the persistent antidepressant effect of ketamine much beyond its half-life.
引用
收藏
页码:709 / 714
页数:6
相关论文
共 38 条
  • [21] Thinking, Walking, Talking: Integratory Motor and Cognitive Brain Function
    Leisman, Gerry
    Moustafa, Ahmed A.
    Shafir, Tal
    [J]. FRONTIERS IN PUBLIC HEALTH, 2016, 4
  • [22] Lener M.S., 2016, BIOL PSYCHIAT
  • [23] The effects of low-dose ketamine on the prefrontal cortex and amygdala in treatment-resistant depression: A randomized controlled study
    Li, Cheng-Ta
    Chen, Mu-Hong
    Lin, Wei-Chen
    Hong, Chen-Jee
    Yang, Bang-Hung
    Liu, Ren-Shyan
    Tu, Pei-Chi
    Su, Tung-Ping
    [J]. HUMAN BRAIN MAPPING, 2016, 37 (03) : 1080 - 1090
  • [24] Prefrontal glucose metabolism in medication-resistant major depression
    Li, Cheng-Ta
    Su, Tung-Ping
    Wang, Shyh-Jen
    Tu, Pei-Chi
    Hsieh, Jen-Chuen
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 2015, 206 (04) : 316 - 323
  • [25] Impaired Prefronto-Thalamic Functional Connectivity as a Key Feature of Treatment-Resistant Depression: A Combined MEG, PET and rTMS Study
    Li, Cheng-Ta
    Chen, Li-Fen
    Tu, Pei-Chi
    Wang, Shyh-Jen
    Chen, Mu-Hong
    Su, Tung-Ping
    Hsieh, Jen-Chuen
    [J]. PLOS ONE, 2013, 8 (08):
  • [26] An efficient biometrics-based remote user authentication scheme using smart cards
    Li, Chun-Ta
    Hwang, Min-Shiang
    [J]. JOURNAL OF NETWORK AND COMPUTER APPLICATIONS, 2010, 33 (01) : 1 - 5
  • [27] Little A, 2009, AM FAM PHYSICIAN, V80, P167
  • [28] The use of standardized uptake values for assessing FDG uptake with PET in oncology: a clinical perspective
    Lucignani, G
    Paganelli, G
    Bombardieri, E
    [J]. NUCLEAR MEDICINE COMMUNICATIONS, 2004, 25 (07) : 651 - 656
  • [29] Regulating action: alternating activation of midline frontal and motor cortical networks
    Luu, P
    Tucker, DM
    [J]. CLINICAL NEUROPHYSIOLOGY, 2001, 112 (07) : 1295 - 1306
  • [30] Outcomes in major depressive disorder:: The evolving concept of remission and its implications for treatment
    Moeller, Hans-Juergen
    [J]. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2008, 9 (02) : 102 - 114